Wednesday, July 8, 2026

biotech · Relapsed/Refractory Multiple Myeloma · Relapsed/Refractory Autoimmune Diseases

Nanjing Legend Biotech

Nanjing Legend Biotech clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

2101 Cottontail Lane, Somerset, New Jersey 08873, US HQ
2,457 Employees
NMPA registrant Type
Company details
Intelligence · Clinical Programs

Nanjing Legend Biotech projects

0 ClinicalTrials.gov programs sponsored by Nanjing Legend Biotech.

Nanjing Legend Biotech has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Nanjing Legend Biotech have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.